Canadian application, no grantCanada
C3a receptor ligands
CA 2303883 A1 · Owner: Lee, Dennis · Inventors: Lee, Dennis
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel C3A ligands are provided. Methods of using the present compunds to treat immune and inflammation disease are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 23, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 23, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 23, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 23, 1998
GrantedNo grant recorded
Term endedSeptember 23, 2018
Patent numberCA 2303883 A1
Classification (IPC)C07C53/12 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.